Chronic excessive activation of glucocorticoid receptors induces obesity, insulin resistance,
glucose intolerance, dyslipidaemia and hypertension. Subtle abnormalities of the …

Objectives. Patients with RA have an increased prevalence of cardiovascular disease
(CVD). This is due to traditional risk factors and the effects of chronic inflammation. MTX is …

Objective Patients with COPD are at risk for cardiovascular events. This is attributed to
increased systemic inflammation. The course of COPD is punctuated by exacerbations …

Background: Glucocorticoids have adverse systemic effects, including obesity, hypertension,
and hyperglycemia, that may predispose to cardiovascular disease. The effect of …

Introduction We analyzed the prevalence of cardiovascular (CV) disease in patients with
rheumatoid arthritis (RA) and its association with traditional CV risk factors, clinical features …

Study objective COPD and cardiovascular disease (CVD) share common risk factors. We
undertook to estimate rates of hospitalization and death from CVD in COPD patients relative …

Objective: To assess whether use of oral glucocorticoids is associated with cardiovascular
and cerebrovascular morbidity. Design and setting: Nested case–control study within a …

RA associates with an increased burden of cardiovascular disease, which is at least partially
attributed to classical risk factors such as hypertension (HT) and dyslipidaemia. HT is highly …

Local glucocorticoid injections are often used to treat joint, soft tissue, or spinal pain, but the
systemic side effects associated with these injections are poorly understood and not well …

Background: Glucocorticoids induce hypercholesterolaemia, a cardiovascular risk factor, in
patients with diseases other than rheumatoid arthritis (RA), but the data in RA are …